Unknown PHASE3 INTERVENTIONAL 4-arm NCT01598337

The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency

The Effect Of Antiplatelets Therapy, Tirafiban, Prasugrel, And Aspirin On Saphenous Vein Coronary Artery Bypass Graft Patency

Sponsor: Prince Sultan Cardiac Center, Adult Cardiology Department.

Conditions Coronary Artery Disease

Interventions Aspirin Clopidogrel Prasugrel Tirofiban

Updated 5 times since 2017 Last updated: May 14, 2012 Started: Apr 30, 2011 Primary completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Coronary Artery Disease and is currently ongoing. Prince Sultan Cardiac Center, Adult Cardiology Department. leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Prince Sultan Cardiac Center, Adult Cardiology Department.

Data source: Prince Sultan Cardiac Center, Adult Cardiology Department.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Riyadh, Saudi Arabia